E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/25/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Biophan receives $5 million convertible credit facility

By Sheri Kasprzak

New York, Jan. 25 - Biophan Solutions, LLC said it has entered into a $5 million convertible credit facility with Biomed Solutions, LLC.

The facility bears interest at 8% annually and is convertible into common shares at $1.46 each.

There is a $1.5 million limit to each draw over a 30-day period and the line of credit agreement expires on June 30, 2007.

Biomed received warrants for up to 1,198,630 shares, exercisable at $1.89 each through Jan. 23, 2011.

Based in Rochester, N.Y., Biophan develops biomedical technologies used with magnetic resonance imaging.

Issuer:Biophan Solutions, LLC
Issue:Credit facility
Amount:$5 million
Maturity:June 30, 2007
Coupon:8%
Price:Par
Yield:8%
Conversion price:$1.46
Warrants:For 1,198,630 shares
Warrant expiration:Jan. 23, 2011
Warrant strike price:$1.89
Investor:Biomed Solutions, LLC
Settlement date:Jan. 24
Stock symbol:OTCBB: BIPH
Stock price:$1.61 at close Jan. 24

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.